Premier Research adopts ERT for enhanced oversight

28-Feb-2017 - Last updated on 28-Feb-2017 at 17:10 GMT

Premier Research has selected ERT’s Trial Oversight suite as its clinical trial management solution to augment sponsor collaboration and help mitigate risk.

According to the company, Premier Research is enhancing customer collaboration by improving operational workflows across study teams.

ERT recently acquired Exco InTouch in order to provide companies with “end-to-end” electronic clinical outcome assessments (eCOA) in addition to patient engagement and digital health solutions.

The company’s clinical trial management solution is powered by its EXPERT® technology platform and enables the contract research organization (CRO) to deliver real-time access to data analytics, key performance metrics, and milestone tracking.

Additionally, Premier Research will now be able to develop electronic Monitoring Visit Reports (eMVR), which allows customers to oversee trials and mitigate risk.

As Outsourcing-Pharma.com previously reported, the clinical trial management solution (CTMS) market is expected to reach nearly $920m by 2021.

According to the report, while pharmaceutical companies account for the largest market share the CRO market is expected to see the highest growth during the foremast period, as companies such as Premier Research continue to adopt the technology.

Simon Britton COO, Premier Research, commented in the release: “ERT has developed an automated approach to study workflows and data aggregation that minimizes data duplication and human error, providing greater visibility and granularity to our study teams and customers.”

(Feature image: iStock/ALotOfPeople)